At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 46 enrolled
Drug / intervention
Blink® Tears eye drops in a multidose bottle +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of Investigational Lubricating Eye Drops
In Brief
A Phase 2 clinical trial evaluating Blink® Tears eye drops in a multidose bottle and Preservative-free investigational lubricating eye drops in a Novelia® eyedropper for Visual Acuity. Completed, enrolled 46 participants across 3 sites.
Detailed Summary
This will be a single-visit, multi-site, randomized, single-masked, bilateral, active-controlled, non-dispensing, 2X2 crossover study.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
202420252026
Enrollment StartApr 2023
First PostedApr 2023
Primary CompletionMay 2023
TodayJul 2026
First PostedApr 14, 2023
Enrollment StartApr 6, 2023
Primary CompletionMay 6, 2023
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 3.2 years ago
Interventions
Blink® Tears eye drops in a multidose bottledrug
Control
Preservative-free investigational lubricating eye drops in a Novelia® eyedropperdrug
Test